7/22/2011· Medical Physics
By: Michael Gossman, MS, DABR, RSO, et al
In the process of radiation oncology department accreditation, surveyors pay close attention to continuous quality improvement in the clinical section.
7/22/2011· Medical Physics
By: Michael Gossman, MS, DABR, RSO, et al
In the process of radiation oncology department accreditation, surveyors pay close attention to continuous quality improvement in the clinical section.
1/2/2010· Medical Physics
By: Michael Gossman, MS, DABR, RSO, et al
Recent improvements to the functionality and stability of implantable pacemakers and cardioverter-defibrillators involve changes that include efficient battery power consumption and radiation hardened electrical circuits. Manufacturers have also pursued MRI-compatibility for these devices
1/3/2010· Medical Physics
By: Michael Gossman, MS, DABR, RSO, et al
As promulgated by the Nuclear Regulatory Commission, packaging regulations for radioactive material are confusing (e.g., “activity” vs “contained” activity vs “total” activity). As a consequence, medical physicists are forced to secondguess the intent of the regulations.
12/31/2009· Medical Physics
By: Michael Gossman, MS, DABR, RSO, et al
Vascular access ports are used widely in the administering of drugs for radiation oncology patients. Their dosimetric effect on radiation therapy delivery in photon beams has not been rigorously established. In this work, the effects on external beam fields when any of a variety of vascular access ports were included in the path of a high energy beam are studied. This study specifically identifies sidescatter and backscatter consequences as well as attenuation effects.
3/13/2012· Medical Physics
Providing Solid Angle Formalism for Skyshine Calculation
By: Michael Gossman, MS, DABR, RSO, et al
We detail, derive and correct the technical use of the solid angle variable identified in formal guidance that relates skyshine calculations to dose-equivalent rate.
7/25/2012· Medical Physics
By: Michael Gossman, MS, DABR, RSO
Abstract-The medical community is advocating for progressive improvement in the design of implantable cardioverter-defibrillators and implantable pacemakers to accommodate elevations in dose limitation criteria.
by Roman L. Weil (Editor), et al
by Anthony Chang, MD, et al
by Errold F. Moody